Multiple Myeloma :: Drug combination slows progression of treatment resistant bone marrow cancer – multiple myeloma
Combining a newly formulated drug with one that is already a standard treatment slows the progression of multiple myeloma, an advanced cancer of the bone marrow cells, according to a clinical trial led by a University of North Carolina at Chapel Hill School of Medicine researcher.